news

NEWS

Precision medicine can slow cancer growth…….. September 2016

22nd September 2016

A clinical trial has found that precision medicine – or tailoring treatment for individual patients – can delay the time it takes for a tumour to grow back in some types of advanced cancer.  This trial took place at Gustave Roussy Cancer Campus in Paris and was presented at the Molecular Analysis for Personalised Therapy ...

more

Kirsty Allsopp presents The Handmade Fair

20th September 2016

16 – 18 September 2016 We had such a great time at Kirsty Allsopp’s The Handmade Fair last weekend with our partners DMC Creative World Ltd The setting was The Green at Hampton Court Palace and although the weather was pretty miserable at times, we met some fantastic people and got to know the team behind our ...

more

URGENT CASTING CALL

15th September 2016

STAND UP TO CANCER and Channel 4 are looking for a single lady who has beaten and survived cancer to take part in a live night of fundraising on Friday 21st October, hosted by Davina McCall, Alan Carr and Adam Hills. Are you aged 18-30 and looking for love or dating? If so, we want to ...

more

Combined HRT breast cancer risk ‘may have been underestimated’

23rd August 2016

“Women who take a common form of HRT are nearly three times as likely to get breast cancer, a major study has found,” the Daily Mail reports. Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of the menopause, such as hot flushes. It replaces hormones that typically drop to a lower level during the ...

more

Statins could be valuable addition to breast cancer treatment

1st June 2016

Scientists have raised the possibility of using statins, cholesterol reducing drugs, to stop some breast cancers returning. The most common form of breast cancer in the UK is oestrogen receptor (ER) positive which uses oestrogen to grow. Hormone therapy drugs such as ‘tamoxifen’ and aromatase inhibitors cut off the supply of oestrogen, reducing the chances the ...

more

Cancer clinical trials to be streamlined to bring new treatments to UK patients sooner

1st June 2016

Earlier this week saw an agreement signed between UK cancer clinical trial centers making new clinical trials easier and more efficient to set up. The Experimental Cancer Medical Centre (ECMC) collaboration agreement will improve the UK’s ability to carry out early phase trials, boosting research to bring new treatments to patients sooner. The UK currently faces ...

more

Encouraging new drug found to inhibit growth of most aggressive type of breast cancer

1st June 2016

According to research published in the journal Oncogene earlier this week, researchers from Nottingham and Oxford Universities have found a new technique to slow the growth of one of the most aggressive forms of breast cancer. The drug, called JQ1, has shown promising results both in vitro and on human cancer cells in mice, and ...

more

Belfast researchers discover potential new way to better tailor treatments for early breast tumours

1st May 2016

Dr Niamh Buckley and her team at Queen’s University Belfast, have discovered a way to predict the likelihood that women who are diagnosed with non-invasive breast cancer will go on to develop an invasive form of the disease. This information could enable doctors to tailor the patient’s treatment to their specific needs. In the UK there ...

more

Scientists hail ‘Milestone’ genetic find for breast cancer

1st May 2016

Personalised treatment for breast cancer could become commonplace as scientists reveal they have compiled the most detailed picture of which genetic mutations are involved in the disease. The findings were published in the journals ‘Nature’ and ‘Nature Communications’ and explain which genes cause healthy breast tissue to turn cancerous. Researchers from the Sanger Institute in Cambridge ...

more

New research gives deeper understanding of why some breast cancers are hard to treat

1st May 2016

Following on from last week’s article Scientists hail ‘Milestone’ genetic find for breast cancer which looked at which mutated genes are more likely to cause cancer, scientists have been able to use this data to analyse that breast cancer can be classified into 10 different diseases. By researching these 10 subtypes of breast cancer scientists at ...

more


Some of the charities who we’ve helped

Please send us an e-mail, write or telephone to:

Jonathan Prince, Trustee. The Pink Ribbon Foundation.
Crofton House, 5 Morley Close, Orpington, Kent BR6 8JR

(t) 01689 858877 (e) enquiries@pinkribbonfoundation.org.uk.

facebook

twitterinstagramyoutubeinsure_pink

The Pink Ribbon Foundation

pink_bow

You can now make a donation
via your mobile phone.
Text PINK33 followed by the amount to 70070 – e.g. to donate £10 text PINK33 £10.

Charity Number 1080839